5天暴涨38%!中国核药龙头,杀入900亿蓝海

谈思生物
May 15, 2025

2025.05.15本文字数:954,阅读时长大约2.4分钟导读:远大医药近期在港股市场表现强劲,股价一周内飙升38%,背后是其在脓毒症治疗和核药领域的两大创新产品取得关键突破。同时,其背后的“远大系”医药帝国布局愈发清晰,涵盖原料药、核药、血制品、中药等多个领域,展现出强大的产业整合能力与创新潜力。在港股仿创药领域,远大医药近期迎来了又一高光时刻。从5月7日至5月13日,其股价在短短一周内累计...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10